Shanghai Jiao Tong University School of Medicine Affiliated Ninth People's Hospital

The Department of Otolaryngology-Head and Neck Surgery at the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine was established in 1951. It is a national key clinical specialty and a key clinical discipline in Shanghai, possessing the Shanghai Key Laboratory of Translational Medicine for Otolaryngology, the Otology Research Institute of Shanghai Jiao Tong University School of Medicine, and the Shanghai Clinical Quality Control Center for Otolaryngology. The department's flagship strengths lie in auditory implantation and neurosurgical procedures of the ear and skull base, with specializations in the reconstruction of ear and nose deformities and comprehensive treatment of head and neck tumors. It is positioned as one of the largest otolaryngology clinical medical centers in China and a core source of advancements in auditory reconstruction technology, moving from simply "being able to hear" to "hearing clearly." In the 2023 China Hospital Specialty Reputation Ranking, it ranked sixth nationwide, and fifth nationwide in the China Hospital Science and Technology Evaluation (STEM) ranking.

Historical Origins and Spiritual Inheritance:

Established in 1951, the department once employed the renowned otolaryngologist Professor He Yongzhao as a consultant. Successive department directors included Sui Dazhong (1951), Mao Chengyue (1956), Hu Guifang (1958), Xu Yuan (1964), Pan Genchang (1982), Wang Ruiping (1988), Wang Quanliang (1989), Tang Junyan (2000), and Wang Peihua (2003). In 2015, the Ninth People's Hospital and the Third People's Hospital officially merged, and the Department of Otolaryngology-Head and Neck Surgery was reorganized and established. The department leader, Professor Wu Hao, currently serves as the Chairman of the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association and the leader of the National Health Commission's Hearing Screening Expert Group. He previously served as the Chairman-elect of the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association. Professor Wu Hao, as the first author, has won one second prize of the National Science and Technology Progress Award (2018), two first prizes of the Ministry of Education Science and Technology Progress Award (2011, 2019), and one first prize of the Shanghai Science and Technology Progress Award (2014).

Core business operational efficiency:

The department has 200 beds, sees 200,000 outpatients annually, and performs over 9,000 surgeries annually, with level 3-4 surgeries accounting for over 60%. It is one of the largest otolaryngology clinical medical centers in China. It comprises the following subspecialties: Auditory Implantation and Neuroskull Base Surgery (Ward 1), Rhinology (Ward 2), Laryngolaryngology-Head and Neck Surgery and Pediatric Otolaryngology (Ward 3), Auditory Implantation Center (East Campus), and subspecialties such as a Hearing Center and an Endoscopic Diagnosis and Treatment Center. The department currently has 38 physicians, including 5 chief physicians, 7 associate chief physicians, 5 doctoral supervisors, and 4 master's supervisors.

Discipline Positioning and Benchmarking:

It is a national key clinical specialty, a key clinical discipline of Shanghai, the chairman unit of the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, and the location of the Shanghai Otolaryngology Clinical Quality Control Center. The department focuses on "ear nerve and skull base surgery, audiology, otolaryngology deformity repair, and comprehensive treatment of head and neck tumors," with a strong emphasis on the diagnosis and treatment of complex and difficult diseases. In 2023, it ranked sixth in the comprehensive ranking of Chinese hospitals' specialties, sixth in the ranking of Chinese hospitals' specialty reputation, fifth in the ranking of Chinese hospitals' science and technology (STEM) values, and second in the ranking of Chinese hospitals' internet influence for otolaryngology-head and neck surgery.

It is a national "Double First-Class" discipline and a national key clinical specialty cluster; ranked 3rd in the national Fudan University Specialty Reputation Ranking for Stomatology; a national clinical medical research center for oral diseases; the birthplace of oral and maxillofacial head and neck tumors, craniofacial deformities, and vascular malformations in China; it has established a complete chain MDT (Multidisciplinary Team) diagnosis and treatment system for oral and maxillofacial tumors, craniofacial deformities, dental and periodontal diseases, implant restorations, orthodontics, and mucosal diseases; and it is benchmarked against the Harvard School of Dentistry in the United States.

The Department of Stomatology at the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine traces its origins back to the School of Stomatology, Shanghai Jiao Tong University, founded in 1932. It is one of the earliest established teaching and clinical bases for stomatology in China. The core of the department—the Department of Oral and Maxillofacial-Head and Neck Oncology—was established in 1953, with Professor Zhang Xize as its first director. Successive department leaders include Professor Zhang Xize, Academician Qiu Weiliu, and Academician Zhang Zhiyuan. Academician Qiu Weiliu is one of the main pioneers of oral and maxillofacial surgery in China, having dedicated over 60 years to medical, teaching, and research work. He specializes in maxillofacial oncology and plastic surgery and is the first academician of the Chinese Academy of Engineering in the field of stomatology in my country. Academician Zhang Zhiyuan, carrying on the legacy of his predecessors, has propelled Chinese oral and maxillofacial surgery to a prominent position on the world stage. He currently serves as the academic leader of the national key discipline of oral and maxillofacial surgery and the director of the National Clinical Research Center for Oral Diseases. Through the passing down of knowledge by generations of academic leaders, including Zhang Xize, Qiu Weiliu, Zhang Zhiyuan, and Shen Guofang, the discipline has cultivated a spirit of "daring to be the first and pursuing excellence," pioneering a "Chinese-style" path for the development of oral and maxillofacial surgery that has garnered global attention.

Core business operational efficiency:

The hospital boasts 5 academicians of the Chinese Academy of Engineering, 3 national key disciplines, 9 national key clinical specialties, and 4 national 211 Project key disciplines. The Department of Stomatology comprises several subspecialties, including Oral and Maxillofacial-Head and Neck Tumors, Oral Surgery, Prosthodontics, Orthodontics, Endodontics, Oral Mucosal Diseases, and Implantology. It serves patients with oral diseases from all over the country annually in its outpatient and emergency services. The Department of Oral Surgery has 57 full-time clinicians, including 19 with senior professional titles and 9 doctoral supervisors. It performs 450 temporomandibular joint arthroscopic surgeries annually, ranking among the world's top. Its temporomandibular joint combined with skull base and mandible reconstruction and repair ranks first in China, with over 1200 surgeries performed annually. In 2023, the Department of Prosthodontics saw 37% more patients than the previous year, ranking among the top in the country in terms of medical volume and capacity. The Department of Endodontics and the Department of Oral Mucosal Diseases each saw over 100,000 outpatient visits annually.

Discipline Positioning and Core Strengths:

Clinical Stomatology is a National Key Discipline (2001), and Oral and Maxillofacial Surgery is a National Key Clinical Specialty (2007). The department is the National Clinical Research Center for Oral Diseases and the National Stomatological Center (Shanghai). It is a council member of the International Association of Oral and Maxillofacial Surgeons (IAOMS), the chair unit of the Oral and Maxillofacial Surgery Committee of the Chinese Stomatological Association, and the chair-elect unit of the Temporomandibular Joint Disease and Orthopaedics Committee of the Chinese Stomatological Association. In the Fudan University's ranking of Chinese hospital specialty reputations, the Department of Stomatology has consistently ranked among the top three in the country for many years. The core advantages can be summarized as a four-dimensional integration: academic inheritance by two academicians × international leadership in the diagnosis and treatment of oral and maxillofacial-head and neck tumors × world-leading minimally invasive temporomandibular joint arthroscopy × domestically pioneering intracranial implant and oral surgery robot. The discipline boasts national-level research platforms such as the National Clinical Research Center for Oral Diseases and the Shanghai Key Laboratory of Stomatology, and has become one of the largest oral and maxillofacial surgery centers in China, holding a leading position domestically and an advanced international level in the fields of oral and maxillofacial tumors, temporomandibular joint diseases, maxillofacial deformity correction, and dental implants. In March 2026, the National Stomatological Center (Shanghai) was officially established at the East Campus of the Ninth People's Hospital, marking a new stage of development for the discipline.

A national key discipline and a national key clinical specialty; ranked No. 1 in the national reputation ranking of plastic surgery for many consecutive years; one of the world's largest medical, teaching and research centers for plastic surgery; the birthplace of plastic and reconstructive surgery, craniofacial surgery and microsurgical repair and reconstruction in China; constructing a complete chain MDT diagnosis and treatment system for congenital malformations, traumatic damage, superficial tumors, organ reconstruction and cosmetic surgery; benchmarked against the Johns Hopkins Plastic Surgery Center in the United States.

The Department of Plastic and Reconstructive Surgery at the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine was founded in 1961 by Professor Zhang Disheng, an academician of the Chinese Academy of Engineering (formerly the Department of Plastic Surgery at Guangci Hospital). It is one of the birthplaces of plastic and reconstructive surgery in my country. Academician Zhang Disheng was a major founder of plastic and reconstructive surgery in my country, a pioneer of microsurgery, and a founder of craniofacial surgery. In 1964, he pioneered the introduction of microsurgery into the field of plastic surgery in my country, creating the new concept of "plastic and reconstructive surgery," which transformed plastic surgery from simply repairing defects to an organic unity of cosmetic repair and functional reconstruction. Through the joint efforts of outstanding experts such as Wang Wei, Guan Wenxiang, Huang Wenyi, Qian Yunliang, and Cao Yilin, the department has cultivated a spirit of "daring to innovate and pursuing excellence." The current department director, Professor Li Qingfeng, is a Changjiang Scholar Professor and a National Outstanding Young Scientist.

Core business operational efficiency:

As of December 2024, the department had 192 physicians, including 102 with senior professional titles, 23 doctoral supervisors, and 21 master's supervisors. It saw 460,000 outpatient and emergency visits annually, and performed 140,000 surgeries and treatments annually, including 16,000 inpatient surgeries. The department has two campuses (North and South), a branch in Pudong, and three outpatient departments, with over 240 beds.

Discipline Positioning and Core Strengths:

The discipline is now a national key discipline (established in 1984), a key construction discipline of the Ministry of Education's "211 Project," a key specialty of the National Health Commission, and the Shanghai Plastic and Reconstructive Surgery Medical Center. It is one of the largest and most influential plastic and reconstructive surgery medical, teaching, and research centers in the world. For fifteen consecutive years, it has been ranked first in the "China Hospital and Specialty Reputation Ranking" for plastic surgery. Its core advantages can be summarized as a four-dimensional integration: "the birthplace of plastic and reconstructive surgery in China × global leadership in full-face preconstruction reconstruction and 'Chinese-style face transplantation' × the only comprehensive treatment center in China for craniofacial surgery, lymphedema, and hemangioma × full-dimensional coverage of seven specialties and 24 professional groups." The department comprises seven specialties: Microsurgical Reconstructive Surgery, Craniofacial Surgery, Lymphedema, Hemangioma and Vascular Malformation, Burn and Plastic Surgery, Hand Surgery, and Cosmetic Surgery. It also includes 24 professional groups such as Craniofacial Deformity, Ear Repair and Reconstruction, Facial Paralysis, Scar Treatment, Rhinoplasty and Reconstruction, Breast Reconstruction, Fat Augmentation, and Facial Rejuvenation. It is the only comprehensive treatment center for craniofacial surgery and lymphedema in Taiwan to date.